13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-09-03 Event 2025-08-29 SEC 0001214659-25-013290 →

TANG CAPITAL MANAGEMENT LLC iTeos Therapeutics, Inc.

Stake: 100.00% Shares: 10,000 CUSIP: 46565G104 Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Item 4 of the Schedule 13D is amended by adding the following: Closing of the Merger: As previously disclosed, each of Concentra, the Issuer and Merger Sub entered into the Merger Agreement, which provides for an Offer by Merger Sub for all of the Issuer's Common Stock. The Offer commenced on August 1, 2025. On August 29, 2025, the Offer expired and Merger Sub accepted for purchase a total of 32,226,407 shares tendered and not withdrawn, representing approximately 72.17% of the total shares of the Issuer issued and outstanding. Following the expiration of the Offer, Merger Sub merged with and into the Issuer on August 29, 2025, pursuant to Section 251(h) of the Delaware General Corporation Law, and, among other things, each share of common stock of Merger Sub issued and outstanding immediately before the Effective Time automatically converted into the right to receive the Offer Price, with the Issuer surviving as a wholly owned subsidiary of Concentra.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
8 13D/G filings on this issuer
7 other filings besides this one
Filer Track Record
5 filings by this filer
4 other filings in the data moat
Short Interest
Not in latest FINRA snapshot

Other 13D/G Filings on iTeos Therapeutics, Inc.

FiledFormFilerStakeShares
2025-05-19 SCHEDULE RA CAPITAL MANAGEMENT, L.P. 4.90% 2,134,806 view →
2025-05-14 SCHEDULE RA CAPITAL MANAGEMENT, L.P. 9.90% 4,163,276 view →
2024-11-18 SC Boxer Capital Management, LLC view →
2022-01-06 SC Boxer Capital, LLC view →
2021-12-10 SC MPM BioVentures 2014, L.P. view →
2021-10-19 SC MPM BioVentures 2014, L.P. view →
2021-09-21 SC MPM BioVentures 2014, L.P. view →

Other Filings by TANG CAPITAL MANAGEMENT LLC

FiledFormIssuerStakeShares
2025-05-19 SCHEDULE Allakos Inc. 100.00% 10,000 view →
2025-04-03 SCHEDULE Allakos Inc. 9.60% 8,693,687 view →
2025-03-04 SCHEDULE Aurinia Pharmaceuticals Inc. AUPH 7.30% 10,029,500 view →
2025-02-27 SCHEDULE ACELYRIN, Inc. 7.30% 7,298,328 view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →